The mission of the Bioinformatics Shared Resource (BIOINF) is to provide state-of-art bioinformatics expertise for the design, analysis, and interpretation of genomics, proteomics, and other high-resolution, high-throughput studies for better understanding of cancer biology, thereby facilitating translation of cancer omics discoveries to cancer treatment. The BIOINF ensures that CCSG investigators have ready access to expert bioinformatics support and services to carry out basic science, translational, clinical, and population-oriented research. BIOINF served a total of 122 Roswell users, of which 90 (74%) were CCSG members. The BIOINF has provided critical value-added bioinformatics services to CCSG programs as evidenced by co-authoring 150 peer-review manuscripts, and serving as co-investigators and/or bioinformaticians on 47 extramural grants. Electronic computational and storage space is a large component in bioinformatics data collection and analysis. The BIOINF takes advantage of two locally available computing resources necessary to provide high-level bioinformatics support. First, through collaboration with the Roswell Park IT department, we have maintained a high-performance cluster with 1,600 processors and 600 TB of high-performance storage. Second, through a formal collaboration with the Center for Computational Research (CCR) at UB, we have ready access to the Linux cluster with more than 8,000 processor cores and 3 PB of high-performance storage.
The Specific Aims of the BIOINF: 1) To collaborate with project investigators by providing methodologic and analytic expertise including study design and conduct, development and implementation of data analytic plans, and interpretation of analysis results; 2) To develop and disseminate innovative open-source bioinformatics software packages; 3) To provide bioinformatics education and training to the cancer center community. The goal of the BIOINF is to continuously supply rigorous and efficient bioinformatics solutions necessary to address the clinical, translational and basic science questions of the investigators we support. Future efforts will focus on developing novel bioinformatics tools to handle emerging and diverse high-throughput data and collaborating with BDS to initiate a joint quarterly educational program for Roswell Park investigators on understanding and using data science to strengthen their research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-42
Application #
9704583
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
42
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :
Zhang, Dingxiao; Tang, Dean G; Rycaj, Kiera (2018) Cancer stem cells: Regulation programs, immunological properties and immunotherapy. Semin Cancer Biol 52:94-106
Gabriel, Emmanuel; Attwood, Kristopher; Al-Sukhni, Eisar et al. (2018) Age-related rates of colorectal cancer and the factors associated with overall survival. J Gastrointest Oncol 9:96-110
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380
Eng, Kevin H; Szender, J Brian; Etter, John Lewis et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14:e1007194
Tubbs, Anthony; Sridharan, Sriram; van Wietmarschen, Niek et al. (2018) Dual Roles of Poly(dA:dT) Tracts in Replication Initiation and Fork Collapse. Cell 174:1127-1142.e19

Showing the most recent 10 out of 1555 publications